MKI67 and prostate carcinoma: We believe the findings reported here, and the identification of the metabolites associated with Gleason score, CAPRA score and Ki67 score in prostate cancer could prove valuable in identifying both; new therapeutic targets for combination therapies as well as providing multiple prognostic indicators (including information on post-treatment biopsies) from data acquired from a single acquisition.